These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3543533)

  • 1. The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.
    Vihko R; Alanko A; Isomaa V; Kauppila A
    Med Oncol Tumor Pharmacother; 1986; 3(3-4):197-210. PubMed ID: 3543533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circannual rhythms in steroid receptor concentration in gynecologic and breast cancers.
    Chambers JT; Lawrence R; MacLusky N; Eisenfield A; Schwartz PE
    Am J Obstet Gynecol; 1987 Mar; 156(3):728-9. PubMed ID: 3826223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progesterone receptors in human ovarian tumors.
    Willcocks D; Toppila M; Hudson CN; Tyler JP; Baird PJ; Eastman CJ
    Gynecol Oncol; 1983 Oct; 16(2):246-53. PubMed ID: 6313494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex steroid receptors in gynecologic cancer.
    Hoffman PG; Siiteri PK
    Obstet Gynecol; 1980 May; 55(5):648-52. PubMed ID: 6988749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol and progesterone receptors in normal ovary and ovarian tumors.
    Lantta M
    Acta Obstet Gynecol Scand; 1984; 63(6):497-503. PubMed ID: 6507051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone receptors in epithelial ovarian malignancies.
    Sutton GP; Senior MB; Strauss JF; Mikuta JJ
    Gynecol Oncol; 1986 Feb; 23(2):176-82. PubMed ID: 3943759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estrogen and progesterone receptors in human ovary and ovarian tumors].
    Han SW; Cao ZY; He B; Wang JH; Chen ML
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Sep; 20(3):253-6. PubMed ID: 2625328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estrogen and progesterone receptor assay in the normal endometrium and endometrial carcinoma].
    Li SY
    Zhonghua Zhong Liu Za Zhi; 1984 Nov; 6(6):429-31. PubMed ID: 6532745
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
    von Minckwitz G; Kaufmann M
    Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Steroid hormone receptors in ovarian carcinomas and their clinical significance].
    Geyer H; Teufel G; de Gregorio G; Pfleiderer A
    Onkologie; 1984 May; 7 Suppl 2():44-52. PubMed ID: 6379538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cytosol estrogen and progestin receptor status in malignant and benign tumors and tumor-like lesions of human ovary.
    Jänne O; Kauppila A; Syrjälä P; Vihko R
    Int J Cancer; 1980 Feb; 25(2):175-9. PubMed ID: 7390646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone cytosol receptor concentration in endometriotic tissue and intrauterine endometrium.
    Bergqvist A; Rannevik G; Thorell J
    Acta Obstet Gynecol Scand Suppl; 1981; 101():53-8. PubMed ID: 6946672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of endocrine responsive breast and endometrial carcinoma using steroid hormone receptors.
    Wittliff JL; Day TG; Dean WL; Allegra JC
    Prog Clin Biol Res; 1988; 276():11-41. PubMed ID: 3051018
    [No Abstract]   [Full Text] [Related]  

  • 16. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
    Utaaker E; Iversen OE; Skaarland E
    Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
    Ehrlich CE; Young PC; Cleary RE
    Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptor content in human ovarian tumors: survival of patients with ovarian carcinoma related to steroid receptor content.
    Iversen OE; Skaarland E; Utaaker E
    Gynecol Oncol; 1986 Jan; 23(1):65-76. PubMed ID: 3943754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
    Spona J; Ulm R; Bieglmayer C; Husslein P
    Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.